By comparison, the predictions under the BRCAPRO model are 3.7% and 0.6% for BRCA1 and BRCA2, respectively, for cases diagnosed under age 36 years and 1.8% and 0.4% for breast cancers diagnosed between ages 36 and 45 years. This evidence concerns the gene BRCA2 and breast cancer.